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PDZ domains are one of the most well studied peptide binding domains. These domains usually 
bind short peptides at the C-terminus of their target proteins and play a crucial role in cellular 
signalling processes. Computational approaches have been published to determine the interaction 
specificity of PDZ domains, but these prediction methods often limit their predictions on a limited 
subset of PDZ domains. In this research work, we developed PreDiZ, a computational method for 
PDZ domain-peptide interaction prediction based on the SDR approach. The SDR approach was 
originally created to predict specificity of protein kinases. In this work, improvements have been 
made to apply the SDR approach to the PDZ domains, including using a more sophisticated 
strategy to determine SDRs, and using both positive and negative interactions in the prediction. As 
a result, PreDiZ is able to work on a wide range of PDZ domains, including novel PDZ domains. In 
cross-validations, PreDiZ scored AUCs range from 0.82 to 0.94. In the comparison against 
published methods, PreDiZ showed competitive performance on making prediction to distantly 
related PDZ domains, but not as good as other recently published methods on mouse test set. 
However, the results also suggested that PreDiZ could be improved by optimising SDRs. We also 
conducted proteome-wide predictions on A. thaliana, C. elegans, D. rerio, M. musculus and H. 
sapiens and showed PDZ domains were evolved relatively late in eukaryotic cells. Network studies 
on human PDZ domain interaction revealed the enriched GO terms and KEGG pathways of PDZ 
domain binding proteins. Lastly, we studied how H7N9’s NA and H5N1’s NS1 protein regulate 
human biological processes using the human PDZ interaction network. Human proteins that 
regulated via PDZ domain interactions by these two kind of viral proteins, were enriched in similar 
biological processes. Therefore, we concluded that the function of PBM in the NS1 proteins of 
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1.1 Peptide-protein interactions 
Proteins often interact with each other to form functional complexes and these 
interactions are important in all biological pathways and signalling mechanisms (1). 
Understanding protein-protein interactions is crucial to the study of protein functions and 
reconstructing biological pathways. It will also help in discovering the functions of new 
proteins by identifying their interaction partners.  
Many proteins have well-structured globular domains. The functions of proteins are 
largely dependent upon these domains. However, disordered regions of proteins also play 
an important role in protein functions (2, 3). Recently, increasing evidence shows that 
linear motifs inherent in these disordered regions play important roles in protein-protein 
interactions. Linear motifs are short peptide sequences containing key residues for 
function or binding (4). They usually form transient complexes with their interaction 
partners. Peptide-protein interactions usually have smaller interacting interfaces and 
weaker interaction affinities compared to interactions between globular domains. The 
transient nature makes linear motifs very good candidates for signalling pathways, which 
require fast response to stimuli (5). 
Experimental methods such as the yeast two-hybrid approach (6, 7), affinity 
purification-mass spectrometry (8) and oriented peptide libraries (9) have been widely 
used to perform large-scale analyses of interactions in different organisms. These 
experimental methods have produced a massive quantity of interaction information, 
however they are also known to be expensive, labour-intensive and time-consuming.  
Moreover, the high-throughput methods may generate false positive results, and therefore 
particular caution is necessary when using these data (10, 11).   
With the rise of bioinformatics in recent years, computational methods can be used 
to complement certain limitations of high-throughput experiments (12). Generally, these 
bioinformatics algorithms can be very helpful for selecting potential targets for 
experimental screening or for validating experimental data. Sometimes, they can even 
provide detailed binding information which might not be found easily using the 
experimental techniques. Hence, they reduce significantly the time and cost required to 
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determining interactions experimentally (13). A number of domains such as SH2, SH3, 
WW, 14-3-3 and PDZ domains have been found to interact with their partners via peptide-
protein interactions. 
1.2 Interaction studies on PDZ domains 
PDZ domain, also named GFGL domain or DHR domain, was first identified in three 
proteins: postsynaptic density protein-95, disks large tumor suppressor and zonula 
occludens-1; and named using the first letter of each of these proteins (14-16). PDZ 
domains are involved in cell signalling and polarity, and mostly found in multi-cellular 
organisms. Hence, it has been suggested that PDZ domains co-evolved with multi-
cellularity (17).  PDZ domains usually consist of 80 to 90 amino acids and fold into a 
globular structure comprising six beta-strands (βA to βF) and two alpha-helices (αA and 
αB). The N- and C-termini of PDZ domains are mostly found close in space. There are 
over 400 structures of PDZ domains in the Protein Data Bank (PDB) (18). These protein 
domains share only around 30% sequence identity on average, but the core structure 
remains the same (19). Furthermore, some PDZ domains contain variable loop regions 
and extension regions that affect their structures and functions (19). Experiments show 
that PDZ domain structures are robust to extensive mutagenesis (20). 
PDZ domains are able to bind short peptides at the C-terminus of their target 
proteins (21). Short C-terminal peptides are recognised by a carboxylate binding loop (βA 
– βB loop), containing the conserved GLGF motif, and the αB helix (22-25). The binding 
peptide binds to the PDZ domain as an anti-parallel extension of the β-sheet of the PDZ 
domain and the ligand residues in positions -1 and -3 point towards to the solvent, while 
residues in positions 0 and -2 point towards to the binding pocket, with the last residue at 
the C-terminus as position 0 (12, 26). PDZ domains are quite promiscuous with their 
specificity; one PDZ domain can interact with multiple peptides and the same peptide can 
be recognised by multiple PDZ domains (27). The specificity of PDZ domains can be 
changed by mutagenesis, which make PDZ domains adapt quickly during evolution (27). 
The PDZ-peptide interactions are regulated by various factors, such as buffer conditions 
(28, 29), allosteric differences (30) and phosphorylation in PDZ-domain binding motives 
(PBM) (31). In addition, some PDZ domains are also able to bind to internal (non-C-
terminal) motifs (32-39) and membrane phospholipids (40-43). 
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Early studies classified PDZ domains into classes based on the last few amino 
acids in their binding peptides (21). Class 1 PDZ domains bind the motif Ser/Thr-X-Ф-
COOH and class 2 PDZ domains bind Ф-X-Ф-COOH, where X is any residue and Ф is a 
hydrophobic residue (26). Less common classes of PDZ domains recognize a different 
motif, Asp/Glu-X-Ф-COOH (22). Later research showed that it was not appropriate to 
classify PDZ domains into three simple classes (44, 45). Tonikian, et al. (46) demonstrated 
that PDZ domains can be classified into up to 16 different classes and the selection 
specificity depended on up to 7 C-terminal residues in their binding peptides. 
Bezprozvanny and Maximov (44) classified PDZ domains into 25 different sub-classes 
based on amino acids in two positions of PDZ domains. Further research on PDZ binding 
specificity showed that every position of the last five C-terminal amino acid of the binding 
peptide affects the binding specificity (47).   
PDZ domain interactions have been experimentally characterised using methods 
such as  immunoprecipitation experiments (48-50), mass spectrometry (51), the yeast two-
hybrid  approach (52), and oriented peptide libraries (9, 21). However, high throughput 
methods are known to be expensive, labour-intensive and time-consuming. With the help 
of computational methods, the time and cost of determining interactions experimentally 
can be reduced. 
1.3 Computational predictive methods of PDZ-peptide interactions 
A number of computational approaches have been published to determine the 
interaction specificity of PDZ domains, as they are one of the most well studied interaction 
domains. These approaches have used sequence information, structure information or 
both to predict specificity of PDZ domains.  
Structure-based methods rely on the information provided from 3D structures of 
PDZ domain-peptide complexes. With the 3D structures available, researchers can study 
in detail how the two proteins interact, as well as the physicochemical properties of the two 
interacting partners (53). On the other hand, these methods are often limited by the lack of 
available 3D structures. There are over 400 PDZ domain structures in the PDB (54), 
compared to 58998 PDZ domain-containing proteins available in the SMART nrdb 
database (55). The lack of coverage of PDZ domains will make it difficult for this kind of 
approaches to predict PDZ domains without known structures. Therefore, most structure-
based methods can only predict interactions with the PDZ domain structure available.  
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Encinar, et al. (56) published a structure-based interaction prediction tool, called 
prediADAN, as part of the ADAN database. It provides position-specific scoring matrices 
for 212 PDZ domains calculated from their high quality structures using a protein design 
algorithm called FoldX (57). Their benchmarking showed an area under receiver operating 
characteristic (AUC) value from 0.48 to 0.96. 
Smith and Kortemme (58) analysed 17 human PDZ domain structures. They used 
Rosetta to simulate and score interactions between large numbers of peptides with five 
residues against these PDZ domain proteins. Then the position specific scoring matrices 
(PSSMs) of PDZ domains were calculated for each domain. They evaluated their method 
on mutated Erbin PDZ domains. For Erbin single point mutation, the method reported an 
AUC value of 0.90 and 0.72 for Erbin with 10 mutations.  
Both structure-based methods described above provide web access, and require a 
protein structure to perform interaction prediction. However, it is not always the case that 
the structure is available for the protein of interest. This will limit the usage of these 
methods. On the other hand, sequence-based methods analyse the amino acid sequences 
of the PDZ domains and their binding partners. Some methods also consider extra 
parameters in their predictions, such as structures, co-localisation and phylogenetic 
profiles. In general, these methods benefit from the large amount of available data for PDZ 
domain interactions (53).  
Stiffler, et al. (59) performed a large scale study on mouse PDZ domains and 
developed a prediction model called multidomain selectivity model (MDSM). They 
identified both positive and negative interactions between 157 mouse PDZ domains 
against 217 peptides using yeast-two-hybrid experiments. By using the positive 
interactions identified, they generated a PSSM for each mouse PDZ domain based on the 
probability of amino acid on last five positions of the positive binding peptides. They were 
able to build PSSMs for 74 mouse PDZ domains. They benchmarked MDSM on 
interactions that weren’t included in the training data and successfully predicted 48% of the 
positive interactions and 88% of the negative interactions. It is worth noting that the 
interaction data published in this study were widely used as training data in almost every 
PDZ domain prediction approach. 
Chen, et al.(60) used a statistical model to predict interactions of mouse PDZ 
domains and peptides by using both sequences of PDZ domains and peptides. They 
constructed a multiple sequence alignment of mouse PDZ domains with available 
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structures in the PDB. Using the structures of α1-syntrophin PDZ and heptapeptide 
GVKESLV as a reference, the model chooses position pairs in close proximity (<5.0 Å). 
They excluded any residue position in the PDZ domains that was not perfectly aligned. 
They obtained 38 interacting pairs involving 16 PDZ-domain binding pocket residues and 5 
peptide ligand residues. They then generated a scoring matrix for each residue pair. This 
model was then fit with affinities or binary interaction data. Cross-validation tests 
(randomly assigning 12% of the domains and 8% of the peptides as the test set) of binary 
interaction showed AUC scores of 0.84, 0.91 and 0.87 for extrapolations to novel mouse 
peptides, novel mouse PDZ domains or both.  They also tested the method on PDZ 
domains from other species. The AUC was 0.77 for D. melanogaster domains and 0.68 for 
C. elegans domains. Chen’s method successfully used PDZ structure to determine the key 
binding sites, then used sequence information to build a predictor that performs at a high 
level on the cross-validations. The method has high accuracy predicting mouse PDZ 
domain interactions. On the other hand, further tests showed that this method was general 
for mouse PDZ domains, but performance for domains derived from more distantly related 
species was not very good. 
Schillinger, et al. (61) developed the domain interaction footprint (DIF) method. This 
method was designed to predict protein-peptide interactions for SH3 and PDZ domains. 
For the PDZ domain part, it used experimentally tested data from four different PDZ 
domains, AF6, SNA1, ERBIN and N1P1. The properties of both binding and non-binding 
peptide sequences of PDZ domains were studied using a machine learning method. 
Parameters such as logP, Verloop parameters for volume, parameters for hydrophobicity, 
polarization, frequency of occurrence in elements of secondary structure, flexibility, and 
surface description were studied using correlation-based feature selection to select the 
best subset of features to classify the binding and non-binding peptides. The selected 
subset was then used to create DIFs for PDZ domains. For a PDZ domain, one DIF for the 
binding and another DIF for the non-binding peptides were created. A peptide is allocated 
to the DIF with the best score. On the ten-fold cross-validation, the DIF method scored an 
average AUC of 0.89, whereas the AUC scores of the single classifiers ranged from 0.84 
to 0.93.  
Kalyoncu, et al. (12) published a PDZ domain interaction prediction and 
classification method, which is based on the sequence features from mouse PDZ domains. 
The training dataset consisted of interaction information from 85 mouse PDZ domains and 
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181 peptides (59). They calculated the frequencies of consecutive two amino acids and 
three amino acids in the amino acid sequences of PDZ domains. Amino acids were 
arranged into seven groups according to their dipoles and volumes of the side-chains. 
Frequencies of consecutive two amino acids (bigram) and three amino acids (trigram) in 
the PDZ domain sequences were used as features to predict their binding partners. Five 
machine learning approaches, which were support vector machine (SVM), nearest 
neighbour, naïve Bayes, J48 and random forest, were trained using 10-fold cross-
validation. In the end, the random forest method was chosen as it out-performed the other 
methods. For the trigram part, this method scored an AUC of 0.97 and 91.4% accuracy on 
their cross-validation. The method was also tested on an unpublished validation dataset 
and scored an accuracy of 79.8%. Kalyoncu’s method showed a very good performance 
on predicting mouse PDZ domain interactions. However, on an unpublished dataset the 
accuracy of the prediction dropped to 79.8%. The tests performed on this method were all 
based on mouse PDZ domains. Performance for PDZ domains on other species was not 
tested.  
The method of Shao, et al. (62) is another sequence-based PDZ domain interaction 
prediction approach. It used a novel regression framework that considers both positive and 
negative interaction data available for mouse PDZ domains. Shao’s method, called semi-
quantitative support vector regression (SVR), predicts the binding affinity of PDZ-peptide 
interactions from quantitative binding data and qualitative non-binding data. SVR is a well-
known machine learning method of non-linear regression. They modified this method to 
take advantage of negative information they had available. They scored an average AUC 
of 0.86 in the benchmarking.  
DomPep developed by Li, et al. (63) is a sequence-based prediction model for 
domain-mediated protein-protein interactions using SVM. They demonstrated their 
approach by building prediction models for PDZ and SH2 domains. They clustered PDZ 
domains in pairs by their positive binding peptides using a parameter called ligand-binding 
similarity (LBS). LBS is positively correlated to the number of shared binding peptides 
between two PDZ domains. Domain sequence identity (DSI) and PWM distance for each 
domain pair was also calculated. PDZ domains with LBS above an arbitrary set cut-off, in 
this case 0.7, were used to determine thresholds of DSI and PWM distance. PDZ domains 
with PWM distance and DSI greater than the corresponding thresholds were considered 
similar in specificity. A SVM algorithm was used to build prediction models for each PDZ 
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domain using binding data from PDZ domains with similar specificity. DomPep scored an 
average AUC of 0.81 on a test set of 52 mouse PDZ domains and an average AUC of 0.84 
on a test set of PDZ domains in other species than mouse. They also compared DomPep 
predictions for three PDZ domains in Scrib, PDZ-1, -2, and -3 with experimental data and 
scored AUC values of 0.90, 0.85 and 0.89 respectively. A web server is available for 
DomPep. 
Kundu and Backofen (64) developed PdzPepInt, a cluster-based prediction method 
for PDZ-peptide interactions. They used the Markov clustering algorithm (MCL) to cluster 
human, mouse, fly and worm PDZ domains based on their sequence identify. PDZ 
domains with sequence identity greater than 50% were considered to have similar binding 
specificity and were therefore grouped together. Then they built a predictive model using a 
Gaussian kernel support vector machine with sequence-based and contact-based feature 
encoding. For the sequence-based approach, they used a strategy similar to DomPep 
(63), considering last five C-terminal residues of binding peptides of each PDZ domain 
group. For the contact-based approach, their approach was similar to Chen’s method (60). 
The sequence-based approach covered 136 PDZ domains and scored an average AUC of 
0.92 on a 5-fold cross-validation test. The contact-based approach covered 70 PDZ 
domains and scored an average AUC of 0.89. A web server is available for the public to 
access this method (65).  
Overall, computational PDZ-peptide prediction methods show high-level 
performances. Some prediction methods limit their predictions on a limited number of 
species such as mouse and human. Other methods show a decrease in performance in 
test sets from other species or PDZ domains without binding data. Some of these 
prediction methods did not provide any convenient way, such as a web interface, for other 
researchers to use them without bioinformatics or programing background. Stiffler’s MSDM 
method (59) provided PSSMs for 74 mouse PDZ domains. DomPep (63) and PdzPepInt 
(64, 65) both have web servers for users to submit their queries and make predictions. 
However, although DomPep claimed it can make predictions for any user-submit PDZ 
domain, this function wasn’t working on their web server at the time of writing.   
1.4 The SDR approach 
The SDR approach was first developed by Brinkworth et al. (66) to predict substrate 
specificities of protein kinases. They identified specificity determining residues (SDR) by 
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analysing the crystal structures of protein kinases. With the assumption of “proteins with 
similar SDR have similar specificity”, protein kinases that contain SDRs similar to the 
query protein were clustered. The binding peptides of these protein kinases are used to 
build PSSMs for the query protein and predict potential ligands. Later on, this approach 
has been proven successful not only for the prediction of phosphorylation sites (67, 68), 
but also prediction of peptide binding to MHC class II proteins (69, 70). In this work, we 
developed PreDiZ, which used the SDR approach to predict PDZ-peptide interactions 
using both structure and sequence information.  
2 Datasets and Methodology 
2.1 Datasets 
2.1.1 PDZ domain structures (PDB) 
The PDZ domain structures were obtained from the RCSB PDB (54). Structures 
that contained at least one PDZ domain and one ligand were extracted. In order to avoid 
low resolution and redundant structures, these structures were further filtered with the 
criteria of resolution higher than 2.4 Å and no more than 95% overall identity. PDZ 
complex structures that represent the canonical PDZ-peptide interaction, where the PDZ 
domain binds to a C-terminal peptide at the GLGF motif, were manually selected. After 
filtering, 22 complex structures were extracted (Table 1). 
Table 1 list of PDZ domain structures extracted from the PDB. 
PDB ID Name 
1BE9 
The third PDZ domain from the synaptic protein PSD-95 in complex with a C-terminal 
peptide derived from CRIPT. 
1IHJ 
Crystal structure of the N-terminal PDZ domain of InaD in complex with a NorpA C-
terminal peptide. 
1KWA Human CASK/LIN-2 PDZ domain. 
1L6O Xenopus Dishevelled PDZ domain. 
1MFG 
The structure of ERBIN PDZ domain bound to the carboxy-terminal tail of the ErbB2 
Receptor. 
1N7F 
Crystal structure of the sixth PDZ domain of GRIP1 in complex with liprin C-terminal 
peptide. 
1OBX 
Crystal structure of the complex of PDZ2 of syntenin with an interleukin 5 receptor 
alpha peptide. 




Crystal structure of the Shank PDZ-ligand complex reveals a class I PDZ interaction 
and a novel PDZ-PDZ dimerization. 
1RZX Crystal Structure of a Par-6 PDZ-peptide complex. 
1TP3 PDZ3 domain of PSD-95 protein complexed with KKETPV peptide ligand. 
1TP5 
Crystal structure of PDZ3 domain of PSD-95 protein complexed with a peptide ligand 
KKETWV. 
1V1T Crystal structure of the PDZ tandem of human syntenin with the TNEYKV peptide. 
1W9E 
Crystal structure of the PDZ tandem of human syntenin in complex with the TNEFYF 
peptide. 
1W9O 
Crystal structure of the PDZ tandem of human syntenin in complex with the TNEYYV 
peptide. 
1W9Q 
Crystal structure of the PDZ tandem of human syntenin in complex with the TNEFAF 
peptide. 
1YBO Crystal structure of the PDZ tandem of human syntenin with the syndecan peptide. 
2AWW 
Synapse associated protein 97 PDZ2 domain variant C378G with C-terminal GluR-A 
peptide. 
2FNE The crystal structure of the 13th PDZ domain of MPDZ. 
2HE2 Crystal structure of the 3rd PDZ domain of human discs large homologue 2, DLG2. 
2I04 X-ray crystal structure of MAGI-1 PDZ1 bound to the C-terminal peptide of HPV18 E6. 
2I0L X-ray crystal structure of Sap97 PDZ2 bound to the C-terminal peptide of HPV18 E6. 
2I1N Crystal structure of the 1st PDZ domain of human DLG3. 
2IWP 12th PDZ domain of multiple PDZ domain protein MPDZ (CASP target).  
2JIL 
Crystal structure of 2nd PDZ domain of glutamate receptor interacting protein-1 
(GRIP1). 
2OPG The crystal structure of the 10th PDZ domain of MPDZ. 
2QBW The crystal structure of PDZ-fibronectin fusion protein. 
2QT5 Crystal structure of GRIP1 PDZ12 in complex with the Fras1 Peptide. 
2R4H 
Crystal structure of a C1190S mutant of the 6th PDZ domain of human membrane 
associated guanylate kinase. 
2V90 
Crystal structure of the 3rd PDZ domain of intestine- and kidney-enriched PDZ domain 
IKEPP (PDZD3). 
2VPH 
Crystal structure of the human protein tyrosine phosphatase, non-receptor type 4, PDZ 
domain. 
2VRF Crystal structure of the human beta-2-syntrophin PDZ domain. 
3B76 
Crystal structure of the third PDZ domain of human ligand-of-numb protein-X (LNX1) in 
complex with the C-terminal peptide from the coxsackievirus and adenovirus receptor. 
3CBY The Dvl2 PDZ domain in complex with the N1 inhibitory peptide. 




2.1.2 PDZ domain-peptide interactions 
PDZ domain-peptide interactions were extracted from published studies, including 
three large-scale studies of PDZ domain interactions in M. musculus (59), H. sapiens (46) 
and C. elegans (71), and an online interaction database (72).  
Stiffler, et al. (59) studied PDZ domain-peptide interactions from 157 mouse PDZ 
domains and 217 genome-encoded peptides using protein microarray screening.  
Equilibrium dissociation constant (KD value) cut-off of 100 µM was used to determine 
positive and negative interactions. There were 726 positive interactions and 16142 
negative interactions extracted, involving 84 PDZ domains and 217 peptides.  
Tonikian, et al. (46) conducted a study on human PDZ domain specificity using 
phage-display experiments. We extracted 1473 positive PDZ domain-peptide interactions 
involving 54 human PDZ domains and 1283 peptides from this study. This study only 
provided positive interaction data, therefore no negative interaction data was collected. 
Lenfant, et al. (71) performed yeast two-hybrid screens to study PDZ domain 
interactions in C. elegans. We collected 396 positive PDZ domain-peptide interactions 
comprising 47 C. elegans PDZ domains and 327 peptides. 
The DOMINO database (72) is a manually curated database of protein interactions. 
Interactions involving a PDZ domain and that were not from the three large scale studies 
above were extracted from the database. We collected 1947 PDZ domain-peptide 
interactions from the DOMINO database. 
2.1.3 Proteome-wide datasets 
Reference proteomes are complete non-redundant proteome sets for selected well-
studied organisms. In this study, reference proteomes of A. thaliana, C. elegans, D. rerio, 
M. musculus and H. sapiens were downloaded from the UniProt database (release 
2014_04) (73) for proteome-wide analyses.  
2.1.4 GO database 
The GO database is a database of Gene Ontologies and annotation of genes and 
gene products (7). In this study, GO database version 2013-03-13 and the gene 
annotation file of version 3/5/2013 were used.   
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2.1.5 Kyoto Encyclopedia of Genes and Genomes pathway database 
The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database is a 
database of manually curated biological pathway maps (74, 75). It is widely used in studies 
such as metabolism, genetic information processing and cellular processes. 
2.1.6 Influenza A virus datasets 
Highly pathogenic avian influenza (HPAI) A virus protein sequences were 
downloaded from the NCBI Influenza Virus Resource database (76) with search conditions 
of “Type:A, Host: Human, Full-length only and collapse identical sequences”. There were a 
total of 33604 virus protein sequences, including 1182 protein sequences from H5N1 and 
218 protein sequences from H7N9. 
2.2 SDR selection based on structural alignments 
2.2.1 PDZ structure-based alignments 
PDZ domain structures were extracted from the PDZ domain-peptide complexes 
from the PDB. These PDZ domain structures were then aligned using PROMALS3D (77), 
a multiple sequence alignment tool using 3D structural information to improve sequence 
alignment quality. Then an HMM profile (referred to as the PDZ HMM profile) was built 
from the structure alignments using the HMMER 3.0 package. The HMM profile of PDZ 
domain structures were later used to determine SDRs.  
2.2.2 Four-parameter-test to identify SDRs 
SDRs were determined for each position of the PDZ binding motif (PBM) 
independently. We designed a four-parameter-test to look at every column of the 
consensus sequence of the PDZ HMM profile. The four parameters were: maximum 
contacting distance (MCD), average column similarity (ACS), proportion of interacting 
residues (PIR) and BLOSUM matrix (BLOSUM). Maximum contacting distance is the 
distance between PDZ domain residue’s side-chain atoms to the closest side-chain atoms 
of their binding peptides. Residues with distance below or equal to the MCD were 
considered as contacting residues. BLOSUM corresponds to the BLOSUM substitution 
matrix used to determine similar residues. Residues with a positive score on the selected 
BLOSUM matrix were considered similar. ACS is the proportion of similar residues on an 
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aligned column of the alignment. PIR is the proportion of contacting residues on an aligned 
column of the alignment. For each position of the PBM (i.e. the last five residues at the C-
terminus), if a column satisfied the condition of all four parameters, it was selected as a 
SDR.  
The SDRs were named based on their positions on the consensus sequence of the 
PDZ HMM profile. Two conserved motifs on the consensus sequence of the PDZ HMM 
profile were selected as marker motifs. They were the GLGF motif located in the βB strand 
and the GD motif located on the βD. The position of a SDR was marked using a marker + 
offset format. For example, if a SDR was on the column two residues after GD, it was 
marked as GD+2. 
2.3 Implementation of the SDR approach 
2.3.1 Customised PDZ interaction database 
Similar to the SDR method on Predikin, a purpose-built protein-peptide interaction 
database of PDZ domain interactions was needed. The database was structured in a 
fashion that the relationship between SDRs and PBM residues could be easily obtained 
(Figure 1). Hence, each PDZ domain in the database was scanned with the PDZ HMMER 
profile and each residue on the PDZ domain was encoded into the motif + offset format. 
There were in total 20494 interactions in this database. 
 
Figure 1 Database schema of the customised PDZ interaction database 
25 
 
2.3.2 PreDiZ prediction module  
In general, PreDiZ predicts binding between PDZ domains and five-residue PBMs 
by establishing a correlation between the SDRs in the query PDZ domains and the SDRs 
associated with known PDZ domain interactions. After the user submits a query, which 
includes at least one PDZ protein and one five-residue peptide sequence (if the submitted 
peptide is longer than 5-residues, only the last 5 residues are used), PreDiZ executes the 
following steps. 
2.3.2.1 Locate SDRs from query protein 
Firstly, PreDiZ identifies all the SDRs for each of the positions of the PBM. The PDZ 
HMM profile built from structural alignments is used to locate PDZ domain(s) on the query 
protein sequence by hmmsearch function from HMMER with the condition of E-value less 
than 0.01. If a PDZ domain is found, SDRs are identified from the sequence alignment of 
the HMM consensus sequence and the query protein. Residues that align to the SDR 
positions of the consensus sequence, correspond to the SDRs for the query PDZ domain.  
2.3.2.2 Query the customised database  
Secondly, PreDiZ queries the customised PDZ interaction database for known PBM 
sequences associated with PDZ domains that share similar SDRs with the query protein at 
each binding position. The term similar SDR is defined as amino acid residues that score 
positively in the selected BLOSUM substitution matrix. Because PreDiZ treats each 
position of the PBM independently, five sets of amino acids are collected for five positions 
of PBM and are used to build a PSSM or a naive Bayesian classifier. 
2.3.2.3 Scoring methods 
2.3.2.3.1 PSSM scoring method 
To construct a PSSM, PreDiZ first calculates the amino-acid frequencies of positive 
interactions for each position from the previous step. A 20 columns (amino acids) x 5 rows 
(5 PBM positions) PSSM based on the amino acid frequency results is built using equation 






         (i) 
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𝑠𝑐𝑜𝑟𝑒 =  
∑ 𝑤𝑖,𝑗−∑ 𝑤𝑚𝑖𝑛,𝑗
∑ 𝑤𝑚𝑎𝑥,𝑗− ∑ 𝑤𝑚𝑖𝑛,𝑗
        (ii) 
where F is the frequency of amino-acid i for PBM position j and n is the number of 
sequences used to calculate the frequency. Note that the PSSM scoring method only uses 
positive binding data to make predictions. 
2.3.2.3.2 Naive Bayesian classifier scoring method 
To utilise both positive and negative interaction data in PreDiZ’s prediction, the 
naive Bayesian classifier is used to build the classification models for query PDZ domains 
from the results of the previous step (2.3.2.2). For each position of the PBM, amino acids 
are categorized into binding or non-binding class, and a vector x = (x1, …, xn) where x1, …, 
xn are the amino acids. Based on Bayesian’s theorem, we get   




where C refer to the binding or non-binding class and 𝑃(𝐶|𝑋1, … , 𝑋𝑛) is the posterior 
probability of the class C. The posterior probability corresponds to 𝑃(𝐶|𝑋1, … , 𝑋𝑛) when C = 
binding is used as the score of the query peptide. 
2.4 Performance evaluation and optimisation 
The performance of PreDiZ was evaluated extensively by 4-, 6-, 8- and 10-fold 
cross-validation. Four standard measurements, including sensitivity (Sn), specificity (Sp), 

























The receiver operating characteristic (ROC) curves were drawn for each cross-





2.4.1 GO and KEGG enrichment analysis of PDZ-binding proteins 
In this study, a statistical approach based on hypergeometric distribution was 
employed to perform enrichment analysis of PDZ-binding proteins in H. sapiens (78). We 
compared the predicted PDZ-binding proteins (group S) against the proteome (group W) to 
find out if a GO/KEGG term t is enriched in the predicted PDZ-binding proteins. The 
following terms were defined: N was the total number of proteins in group W annotated by 
GO/KEGG; n was the number of proteins in group W annotated by GO/KEGG term t; M 
was the total number of proteins in group S annotated by GO/KEGG; m was the number of 
proteins in group S annotated by GO/KEGG term t. Hence,  




















    
or 













Here, we considered only the over representation of GO/KEGG groups with enrichment 






3.1 Computational approach to predict PDZ domain-peptide interactions (PreDiZ) 
3.1.1 Construction of PreDiZ for the prediction of PDZ domain interactions 
In this work, we developed a computational tool called PreDiZ to predict peptide-protein 
interactions involving PDZ domains based on the SDR approach (66-68, 79). The 
procedures used for data preparation and prediction making are shown in Figure 2. PreDiZ 
is able to predict the binding between any PDZ domain and any 5-residue-long peptide. It 




Figure 2 A schematic representation of PreDiZ. SDR determination: PDZ domain structures were 
then aligned using PROMALS3D. Then an HMM profile was built from the structure alignments 
using the HMMER 3.0 package. The HMM profile of PDZ domain structures were later used to 
determine SDRs. PDZ binding prediction: PreDiZ identifies all the SDRs for each of the positions 
of the PBM. The PDZ HMM profile built from structural alignments is used to locate PDZ domain(s) 
on the query protein sequence. If a PDZ domain is found, SDRs are identified from the sequence 
alignment of the HMM consensus sequence and the query protein. Residues that align to the SDR 
positions of the consensus sequence, correspond to the SDRs for the query PDZ domain. Model 
construction: PreDiZ queries the customised PDZ interaction database for known PBM 
sequences associated with PDZ domains that share similar SDRs with the query protein at each 
binding position. Because PreDiZ treats each position of the PBM independently, five sets of amino 
acids are collected for five positions of PBM and are used to build a PSSM or a naive Bayesian 
classifier. The PSSM or the naive Bayesian classifier is used to score PDZ domain-binding motifs. 
3.1.2 Performance evaluation and optimisation 
3.1.2.1 SDR selection and cross-validations 
SDR selection is critical for the performance of PreDiZ. In this work we performed 
extensive tests to select the best SDR set for PDZ binding prediction. Firstly, structural 
alignment was performed with 22 PDZ domain structures from the PDB. From this 
alignment, we determined 128 groups of SDRs according to combinations of four 
parameters: average column similarity (ACS) of 0.2, 0.4, 0.6, 0.8, proportion of interacting 
residues (PIR) of 0.2, 0.4, 0.6, 0.8, maximum contacting distance (MCD) of 5 Å, 6 Å, 8 Å, 
10 Å, and BLOSUM matrix (BLOSUM) of BLOSUM62, BLOSUM80. The SDR set with the 
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best area-under-ROC curves (AUC) from the cross-validation tests was used in the final 
version of PreDiZ. Both the position-specific scoring matrix scoring method (PreDiZ-PSSM) 
and the naive Bayesian scoring method (PreDiZ-NB) were tested. For the PreDiZ–PSSM 
method, PreDiZ used only the positive binding data of PDZ interactions and performed 
best when used the SDR selected using from ACS = 0.8, PIR = 0.8, MCD = 10 Å and 
BLOSUM = BLOSUM62 parameters (Table 2, Figure 3). The resulting AUC’s values were 
0.812, 0.811, 0.812 and 0.812 for 4-, 6-, 8- and 10-fold cross-validation, respectively 
(Figure 4). For the PreDiZ–NB method, which using both positive and negative binding 
data of PDZ interactions, the same SDR set gave the best results with AUC of 0.885, 
0.883, 0.879 and 0.886 for 4-, 6-, 8- and 10-fold cross-validation, respectively (Figure 5). 
The performance of the 10-fold validations was used for determining the cut-offs. If a pair 
of PDZ protein and PBM gave a score higher than the cut-off value, it was considered 
positive, otherwise negative. Three levels of thresholds were selected (Table 3). The High 





Figure 3 3D structure of a representative PDZ domain (PDB ID 1TP5) with SDRs highlighted in red. 
The PDZ domain is shown in grey and the peptide is shown in cyan. 
 
Table 2 SDR set used in the PreDiZ 
Position SDR in motif + offset format 
0 GLGF -3 GLGF 1 GD -15 GD -11 GD 20 
-1 GLGF -3 GLGF 1 GD -15 
  -2 GLGF 1 GLGF 3 
   -3 GLGF 1 GLGF 3 





Figure 4 ROC curves of cross-validations for PreDiZ-PSSM 
 




Table 3 Performance evaluations of PreDiZ 
Predictor Threshold ACC (%) TPR (%) SPC (%) MCC 
PreDiZ - PSSM High 88.35  33.14  97.06  0.4047 
 
Medium 84.60  50.34  90.00  0.3825 
 
Low 80.23  69.54  81.91  0.4079 
PreDiZ - NB High 91.60  55.98  96.89  0.5919 
 
Medium 87.48 70.45 90 0.5291 
 Low 83.96 76.9 85 0.4925 
ACC stands for accuracy. TPR stands for true positive rate or sensitivity. SPC stands for specificity. 
MCC stands for the Matthew’s correlation coefficient. 
3.1.2.2 Performance comparison with published methods  
3.1.2.2.1 Performance evaluation on unpublished mouse interaction data 
We compared PreDiZ with three state-of-the art PDZ interaction prediction tools, 
MDSM, DomPep and PdzPepInt. An independent test set consisting of interactions 
between 74 mouse PDZ domains and 48 peptides was used in this test. There were in 
total 493 positive interactions and 3059 negative interactions. From this test set, 
interactions involving 50 PDZ domains that were shared in all the prediction methods were 
selected. These interactions were carefully excluded from the training data of PreDiZ. The 
comparison results (Table 4) showed that the performance of PreDiZ-PSSM achieved an 
AUC of 0.78, which was better than MDSM’s AUC of 0.74, but not as good as PdzPepInt 
and DomPep which scored 0.85 and 0.84, respectively. PreDiZ-NB performed worst 
among all the prediction methods in the test, with an AUC of 0.67. PreDiZ-NB also scored 
the worst true-positive/false-positive (TP/FP) ratios of 0.36, 0.25 and 0.24 for high, medium 
and low threshold respectively, which suggested this method made more false positive 
predictions than the others. PreDiZ-PSSM achieved the best TP/FP ratio of 1.12 at high 
threshold, but the true positive rate (TPR) was 0.36, which was around half of the TRP of 
PdzPepInt or DomPep. 
Table 4 Performance evaluation on the independent mouse test set 
Predictor Threshold TPR FPR TP/FP AUC 
PreDiZ - NB High 0.43 0.2 0.36 0.67 
 
Medium 0.69 0.45 0.25 
 
 
Low 0.8 0.54 0.24 




Medium 0.57 0.21 0.51 
 
 
Low 0.79 0.32 0.45 
 MDSM 
 
0.55 0.17 0.55 0.74 
PdzPepInt 
 
0.67 0.14 0.87 0.85 
DomPep   0.66 0.15 0.79 0.84 
TRP is true positive rate, FPR is false positive rate, TP/FP is true-positive/false-positive ratio. 
In another experiment, we tested PreDiZ on a test set of 20 mouse PDZ domain-
peptide interactions derived from PDZbase (80). This test set has been used to compare 
performance of MDSM and PdzPepInt (64). Both PreDiZ-PSSM and PreDiZ-NB were 
tested using the high threshold. The results showed PdzPepInt performed best by 
successfully predicting 14 out of 20 interactions. While PreDiZ-NB was the worst predictor, 
which only managed to predict one interaction. PreDiZ-PSSM predicted 8 interactions, 
which was better than MDSM’s 4 interactions, but still not as good as the PdzPepInt’s 
result. All prediction scores for the validated set were listed in Table 5. 
Table 5 PdzPepInt, MDSM and PreDiZ scores for validated set. 
PDZ domain Peptide PdzPepInt MDSM PreDiZ - NB PreDiZ - PSSM 
Cipp-(3/10) IESDV 0.44 -0.7 0.86 0.73 
Cipp-(3/10) LESEV 0.3 -0.62 0.68 0.71 
Cipp-(3/10) QQSNV 0.29 -0.78 0.67 0.51 
Cipp-(3/10) KEYYV 0.51 -0.34 0.42 0.66 
Dvl1-(1/1) SETSV -1.27 -0.74 0.22 0.51 
Pdlim5-(1/1) DITSL -0.24 -0.15 0.29 0.42 
Erbin-(1/1) LDVPV 0.99 0.61 0.11 0.42 
Magi-2-(5/6) KESSL 1.76 0.19 0.005 0.21 
MUPP1-(10/13) IATLV 1 0.46 0.49 0.64 
MUPP1-(10/13) GKDYV 1 1.68 0.03 0.41 
NHERF-1-(1/2) FDTPL 1.06 0.01 0.99 0.89 
LIN-7A-(1/1) IESDV 0.33 0.29 0.83 0.77 
Lin7c-(1/1) IESDV 0.33 1 0.83 0.77 
ZO-3-(1/3) GKDYV 0.99 0.09 0.35 0.4 
a1-syntrophin-(1/1) VLSSV -1.47 0.16 0.49 0.47 
PSD95-(1/3) LQTEV 0.38 1.41 0.79 0.76 
PSD95-(1/3) NETVV -1.35 1.19 0.73 0.85 
PSD95-(1/3) GETAV -1.32 1.23 0.74 0.86 
PSD95-(1/3) EESSV -2.23 0.77 0.17 0.62 
PSD95-(1/3) RTTPV 1 0.61 0.73 0.81 
Scores marked red are the true positive interactions. 
3.1.2.2.2 Prediction comparison on novel PDZ domains 
Both DomPep and PdzPepInt claimed that they are able to predict interactions for 
unknown PDZ domains, as does PreDiZ. Therefore, we designed an experiment to test the 
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performance of making prediction on unknown PDZ domains for these prediction methods. 
At the time of writing DomPep webserver returned an error on any user-submitted PDZ 
domains. Hence, we could only make comparisons between PdzPepInt and PreDiZ. We 
used 251 PDZ domain-peptide interactions from C. elegans, which the PDZ domains were 
not modelled in PdzPepInt and these interactions were excluded from the training set of 
PreDiZ. PdzpepInt was able to correctly predict 4 interactions, while PreDiZ-NB with high 
threshold predicted 8 and PreDiZ-PSSM predicted 5. Both methods therefore showed a 
similar level of performance on predicting unknown PDZ interactions (Table 6).  
Table 6 Performance evaluation between PreDiZ and PdzPepInt on unknown PDZ domains 




PreDiZ - NB High 8 0.03 
 
Medium 17 0.07 
 
Low 23 0.09 
PreDiZ - PSSM High 5 0.02 
 
Medium 8 0.03 
 Low 18 0.07 
 
3.2 Proteome-wide analysis 
3.2.1 Proteome-wide PDZ domain-peptide interaction predictions 
Proteome-wide prediction of PDZ domain mediated interactions in A. thaliana, C. 
elegans, D. rerio, M. musculus and H. sapiens were performed. We retrieved 26577, 
20310, 25418, 21966 and 20661 proteins from A. thaliana, C. elegans, D. rerio, M. 
musculus and H. sapiens reference proteomes, respectively. We scanned these 
proteomes with PreDiZ to identified PDZ domains and predict their binding partners. The 
results showed PDZ domains exist in 0.02%, 0.24%, 0.90%, 0.60% and 0.68% of the 
proteins in A. thaliana, C. elegans, D. rerio, M. musculus and H. sapiens proteomes, 
respectively (Table 7). Around one third of the proteome was predicted with the ability to 
bind PDZ domains for D. rerio, M. musculus and H. sapiens, while 2.82% for D. 
melanogaster and 6.10% for C. elegans. 
Table 7 Proteomic prediction of 5 species PDZ interactions 
Organism Proteome 
PDZ PDZ-binding (PSSM) 
Num. Per. Num. Per. 
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A. thaliana 26577 6 0.02% 749 2.82% 
C.  elegans 20310 49 0.24% 1238 6.10% 
D. rerio 25418 229 0.90% 9144 35.97% 
M. musculus 21966 132 0.60% 7589 34.55% 
H. sapiens 20661 140 0.68% 7212 34.91% 
 
3.2.2 GO/KEGG enrichment analysis of human PDZ domains 
Using the predicted H. sapiens PDZ interactions, a PDZ interaction network was 
constructed with 140 PDZ proteins and 7212 PDZ binding proteins. The top 10 
interconnected PDZ domains and PDZ binding proteins are listed (Figure 6). 
Hypergeometric distribution tests (p-value < 1E-3) were performed to analyse the 
enrichment of GO terms for proteins in the network. The results show that the network is 
significantly enriched with proteins locating to the membrane and involving a number of 
biological processes such as small GTPase-mediated signal transduction, steroid 
metabolic process and xenobiotic metabolic processes (Table 8). Similar statistical tests 
were also performed to test the enrichment of KEGG pathways. The results suggested the 
network proteins were associated in pathways such as metabolism of xenobiotics by 
cytochrome P450, drug metabolism by cytochrome P450 and epithelial cell signalling in H. 
pylori infection (Table 4). These results are consistent with our knowledge of PDZ domains. 
For example, PDZ domains are known to interact with xenobiotic transporters (81). The 
involvement of PDZ domains in other top-ranking biological processes, such as small 
GTPase mediated signal transduction (82, 83), steroid metabolic process (84, 85) and 




Figure 6 Interaction network of human PDZ interactions and statistics. (a) Interaction network of 
human PDZ interactions. (b) Proteins targeted by most PDZ domains. (c) PDZ domain proteins 
with most binding partners. 
 
Table 8 The most enriched GO terms in the H. sapiens PDZ interaction network (p-value < 1E-3) 
Term Description 
PDZ Domain Proteome E-
ratio 
p-value 
Num. Per. Num. Per. 
The most enriched biological processes 
      small GTPase mediated signal 
transduction (GO:0007264) 186 2.37% 326 1.79% 1.32 2.10E-07 
regulation of small GTPase mediated 
signal transduction (GO:0051056) 90 1.15% 147 0.81% 1.42 6.62E-06 
steroid metabolic process (GO:0008202) 42 0.54% 61 0.34% 1.60 4.13E-05 
xenobiotic metabolic process 
(GO:0006805) 81 1.03% 136 0.75% 1.38 7.54E-05 
regulation of proteolysis (GO:0030162) 29 0.37% 40 0.22% 1.68 1.55E-04 
glycosaminoglycan biosynthetic process 
(GO:0006024) 26 0.33% 35 0.19% 1.72 1.77E-04 
auditory receptor cell differentiation 
(GO:0042491) 10 0.13% 10 0.05% 2.32 2.19E-04 
protein homooligomerization 
(GO:0051260) 85 1.08% 150 0.82% 1.32 5.27E-04 
neural tube formation (GO:0001841) 11 0.14% 12 0.07% 2.13 6.84E-04 
cellular response to zinc ion (GO:0071294) 11 0.14% 12 0.07% 2.13 6.84E-04 
regulation of protein stability 
(GO:0031647) 20 0.26% 27 0.15% 1.72 1.08E-03 
positive regulation of phosphorylation 
(GO:0042327) 17 0.22% 22 0.12% 1.79 1.18E-03 
daunorubicin metabolic process 
(GO:0044597) 8 0.10% 8 0.04% 2.32 1.18E-03 
sulfation (GO:0051923) 8 0.10% 8 0.04% 2.32 1.18E-03 






fertilization (GO:0009566) 21 0.27% 29 0.16% 1.68 1.32E-03 
ATP hydrolysis coupled proton transport 
(GO:0015991) 21 0.27% 30 0.16% 1.63 2.62E-03 
transferrin transport (GO:0033572) 21 0.27% 30 0.16% 1.63 2.62E-03 
       
The most enriched molecular functions 
      
PDZ domain binding (GO:0030165) 55 0.70% 75 0.41% 1.70 9.96E-08 
glutathione transferase activity 
(GO:0004364) 20 0.26% 25 0.14% 1.86 1.83E-04 
sulfotransferase activity (GO:0008146) 21 0.27% 27 0.15% 1.81 2.58E-04 
aldo-keto reductase (NADP) activity 
(GO:0004033) 9 0.11% 9 0.05% 2.32 5.08E-04 
oxidoreductase activity, acting on 
NAD(P)H, quinone or similar compound as 
acceptor (GO:0016655) 8 0.10% 8 0.04% 2.32 1.18E-03 
alditol:NADP+ 1-oxidoreductase activity 
(GO:0004032) 8 0.10% 8 0.04% 2.32 1.18E-03 
polysaccharide binding (GO:0030247) 10 0.13% 11 0.06% 2.11 1.47E-03 
delayed rectifier potassium channel activity 
(GO:0005251) 24 0.31% 35 0.19% 1.59 2.04E-03 
cytochrome-b5 reductase activity, acting 
on NAD(P)H (GO:0004128) 7 0.09% 7 0.04% 2.32 2.74E-03 
cyclin-dependent protein serine/threonine 
kinase activity (GO:0004693) 22 0.28% 32 0.18% 1.60 2.97E-03 
calcium channel regulator activity 
(GO:0005246) 14 0.18% 18 0.10% 1.81 2.98E-03 
       
The most enriched cellular components 
      
apical plasma membrane (GO:0016324) 115 1.47% 210 1.15% 1.27 3.99E-04 
clathrin adaptor complex (GO:0030131) 14 0.18% 17 0.09% 1.91 1.10E-03 
plasma membrane (GO:0005886) 1556 19.85% 3436 18.88% 1.05 1.91E-03 
Golgi lumen (GO:0005796) 46 0.59% 77 0.42% 1.39 2.33E-03 
Golgi apparatus (GO:0005794) 321 4.09% 667 3.66% 1.12 4.14E-03 
nuclear speck (GO:0016607) 81 1.03% 150 0.82% 1.25 4.41E-03 
Golgi membrane (GO:0000139) 219 2.79% 447 2.46% 1.14 6.12E-03 
PCAF complex (GO:0000125) 6 0.08% 6 0.03% 2.32 6.37E-03 
early endosome (GO:0005769) 71 0.91% 132 0.73% 1.25 8.28E-03 
endocytic vesicle (GO:0030139) 23 0.29% 36 0.20% 1.48 9.47E-03 
heterotrimeric G-protein complex 
(GO:0005834) 23 0.29% 36 0.20% 1.48 9.47E-03 
adherens junction (GO:0005912) 23 0.29% 36 0.20% 1.48 9.47E-03 
 






  E-ratio p-value 
Num. Per. Num. Per. 
Metabolism of xenobiotics by cytochrome 
P450(path:hsa00980) 54 1.98% 76 1.23% 1.61 1.80E-06 
Drug metabolism - cytochrome P450(path:hsa00982) 47 1.72% 68 1.10% 1.56 2.73E-05 
Epithelial cell signalling in Helicobacter pylori 
infection(path:hsa05120) 46 1.68% 68 1.10% 1.53 7.70E-05 
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Regulation of autophagy(path:hsa04140) 25 0.92% 32 0.52% 1.77 9.55E-05 
Endocrine and other factor-regulated calcium 
reabsorption(path:hsa04961) 32 1.17% 49 0.79% 1.48 2.32E-03 
Synaptic vesicle cycle(path:hsa04721) 39 1.43% 64 1.04% 1.38 5.10E-03 
Huntington's disease(path:hsa05016) 98 3.59% 182 2.95% 1.22 5.18E-03 
Collecting duct acid secretion(path:hsa04966) 19 0.70% 27 0.44% 1.59 5.42E-03 
Cardiac muscle contraction(path:hsa04260) 45 1.65% 76 1.23% 1.34 5.89E-03 
 
3.3 PDZ-binding motifs in influenza virus A 
3.3.1 Interaction predictions of human PDZ domains and virus proteins 
In 2013, a novel avian-origin influenza A virus H7N9 has emerged in China, 
infecting over 160 patients. Highly pathogenic avian influenza (HPAI) A virus, such as 
H5N1, are known to contain a PDZ domain binding motif at the C-terminus of the NS1 
protein. This motif is able to affect virulence, but not the replication of the virus (88, 89). 
However, the PDZ domain-binding motif (PBM) is not found in the recent H7N9’s NS1 
proteins, but is found in the NA proteins instead (90). 
To investigate how these changes affect the virus regulating human cells through 
PDZ binding, PrediZ was used to predict the binding between human PDZ proteins from 
the previously generated human PDZ interaction network and the HPAI H5N1’s NS1 
proteins and HPAI H7N9’s NA proteins. The PDZ domains, that were predicted to bind the 
viral proteins, were mapped to the human PDZ interaction network to find their binding 
partners. The results revealed that all H7N9’s NA proteins and 96.72% H5N1’s NS1 
proteins were predicted to interact with at least one PDZ domain. H7N9’s NA proteins are 
targeted by 20 different human PDZ domains, while H5N1’s NS1 are targeted by 18. The 
number of human proteins that interact with these PDZ domains is similar, with 3366 
proteins for H7N9’s NA and 4238 for H5N1’s NS1 (Table 10).  
Table 10 Predicted PDZ interaction in HAPI influenza A viral proteins 





H7N9 NA 26 26 100.00% 20 3366 
H5N1 NS1 118 122 96.72% 18 4238 
* hit means the protein is predicted to interact with at least one PDZ domain. 
 
To further validate how H5N1’s NS1 proteins and H7N9’s NA proteins affect the 
virus regulation human cells by the virus, we analysed the PDZ binding proteins related to 
39 
 
these two viral proteins by comparing their enrichment of biological process of GO 
ontology. The results showed two sets of protein enriched in similar biological processes 
by sharing 6 out of 10 most enriched biological processes (Table 11, Table 12).  




Num. Per. Num. Per. 
Top 10 most enriched biological processes 
      transmembrane transport (GO:0055085) 22 9.36% 449 2.47% 3.80 9.44E-08 
glutamate receptor signaling pathway (GO:0007215) 5 2.13% 13 0.07% 29.79 4.07E-07 
actin crosslink formation (GO:0051764) 4 1.70% 8 0.04% 38.73 1.82E-06 
Wnt receptor signaling pathway, calcium modulating pathway 
(GO:0007223) 
4 1.70% 11 0.06% 28.17 8.32E-06 
muscular septum morphogenesis (GO:0003150) 3 1.28% 4 0.02% 58.09 8.42E-06 
glossopharyngeal nerve morphogenesis (GO:0021615) 3 1.28% 4 0.02% 58.09 8.42E-06 
G-protein coupled receptor signaling pathway (GO:0007186) 15 6.38% 301 1.65% 3.86 9.12E-06 
brain development (GO:0007420) 11 4.68% 170 0.93% 5.01 1.34E-05 
membranous septum morphogenesis (GO:0003149) 3 1.28% 5 0.03% 46.47 2.08E-05 
startle response (GO:0001964) 3 1.28% 6 0.03% 38.73 4.13E-05 
 
Table 12 GO enrichment analyse of H7N9 NA related PDZ binding proteins 
Term Description 
PDZ Domain Proteome E-ratio p-value 
Num. Per. Num. Per.     
Top 10 most enriched biological processes 
      transmembrane transport (GO:0055085) 30 10.56% 449 2.47% 4.28  2.15E-11 
glutamate receptor signaling pathway (GO:0007215) 5 1.76% 13 0.07% 24.65  1.04E-06 
ion transmembrane transport (GO:0034220) 8 2.82% 56 0.31% 9.16  2.36E-06 
actin crosslink formation (GO:0051764) 4 1.41% 8 0.04% 32.05  3.87E-06 
potassium ion transport (GO:0006813) 9 3.17% 83 0.46% 6.95  5.78E-06 
muscular septum morphogenesis (GO:0003150) 3 1.06% 4 0.02% 48.07  1.49E-05 
Wnt receptor signaling pathway, calcium modulating 
pathway (GO:0007223) 4 1.41% 11 0.06% 23.31  1.76E-05 
regulation of small GTPase mediated signal 
transduction (GO:0051056) 11 3.87% 147 0.81% 4.80  1.99E-05 
synaptic transmission (GO:0007268) 18 6.34% 381 2.09% 3.03  3.26E-05 
membranous septum morphogenesis (GO:0003149) 3 1.06% 5 0.03% 38.45  3.67E-05 
 
4 Discussion 
4.1 New developments on the SDR approach 
We have presented a PDZ domain-peptide interaction prediction tool based on the 
SDR approach, called PreDiZ. The SDR approach was first developed to predict specificity 
of protein kinases and showed the potential of working on other peptide recognition 
proteins (66). It was later applied in Predivac to predict CD4+ T-cell epitopes (69). In this 
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work, we successfully adapted the SDR approach on another peptide recognition domain, 
the PDZ domain. Unlike other methods that build models for individual domains or a group 
of domains, PreDiZ analyses the SDRs on each PDZ domain and constructs a specific 
model according to these SDRs. Hence, PreDiZ isn’t limited to predicting interactions for 
known PDZ domains, but also able to make prediction for novel PDZ domains. 
 
4.1.1 Using a four-parameter-test as the SDR selection strategy 
A number of improvements have been made to the SDR approach to apply it to the 
PDZ domains. First of all, a four-parameter-test (described in 2.2.2) was introduced to 
select SDRs. In previous tools using the SDR approach, i.e. Predikin and Predivac, 
residues within 5 Å distance between PDZ domain residue’s side-chain atoms to the 
closest side-chain atoms of their binding peptides were selected as SDRs. Here, we used 
the four-parameter-test that determines SDRs from structural alignments, by filtering each 
column of the alignment with four parameters, including MCD, ACS, PIR and BLOSUM. 
Therefore, SDRs were selected not only based on the contact distance, but also the amino 
acid similarity of each column. This test was designed based on the theory that SDR is 
likely to be located at the position that is in close proximity of the binding peptide but not 
conserved across the PDZ domains. Hence, SDRs that affect the binding specificity either 
through direct contact or in indirect ways can all be considered. Furthermore, this test can 
be easily applied to other protein domains. In this study, the SDR set with the best 
performance was used MCD = 10 Å (3.1.2.1), as a typical Van der Waal interaction’s 
contacting distance is normally less than 5 Å. This result supported our opinion of the 
specificity of PDZ domain isn’t only affected by residues making direct contact. A recent 
study analysing 28 ligand-bound PDZ structures revealed structural determinants of 
peptide binding specificity for each of the last four residue of the binding peptide (91). 
Comparing these results and SDRs from PreDiZ, most of the SDRs we used were also 
found in this study (Table 2, Table 13). Another study used molecular dynamics 
simulations to analyse PDZ domain-peptide complexes with known binding affinities (92). 
The study identified 13 binding pocket residues on the PDZ domain structure 1TP3. Four 
out of six SDRs we used were in these binding pocket residues. The SDRs identified for 
PreDiZ were therefore consistent with the findings in the literature. 
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Table 13 SDRs presented in Ernst’s study 
Position SDRs SDRs converted into motif + offset 
format 
0 β1:β2-7, β2-1, β2-3, α2-5, α2-8 GLGF-2, GLGF0, GLGF2, GD20, 
GD23 
-1 β2-2, β2-4, β3:α1-1, β3-5 GLGF1, GLGF3, GD-15, GD-13 
-2 β2-2, α2-1, α2-5 GLGF1, GD16, GD20 
-3 β2-2, β2-4, β3-4, β3-5 GLGF1, GLGF3, GD-16, GD-15 
4.1.2 Using both positive and negative interactions in the prediction 
We employed the naive Bayesian classifier as an alternative scoring method in 
PreDiZ, to take the advantage of having both positive and negative interactions available 
for the PDZ domains. Both Predikin and Predivac used PSSM scoring methods, where 
only positive interactions were taken into account. In our case, negative interaction data 
were available for PDZ domains, therefore the naive Bayesian classifier scoring method 
(PreDiZ-NB) was employed as an alternative scoring method, in addition to the PSSM 
method (PreDiZ-PSSM). As expected, the performance of PreDiZ-NB was better than the 
PreDiZ-PSSM in the cross-validation tests, improving the AUC from 0.82 to 0.88. Despite 
the better scores in the cross-validation tests, PreDiZ-NB’s AUC was only 0.67 using on 
the mouse test set of 50 mouse PDZ domains and 48 peptides, compared to PreDiZ-
PSSM’s AUC of 0.78 (3.1.2.2.1). This result was due to PreDiZ-NB predicting a large 
number of false positives. The predictions for individual PDZ domain showed PreDiZ did 
better in some PDZ domains than others. It is suggested that PreDiZ could be trained to 
perform well on the training set, but the selected SDRs are not specific enough to 
distinguish the interactions in some PDZ domains from this specific mouse test set. This 
mouse available test set is the only test data that with negative interactions. There is no 
any other test data to further validate either of these contradictory results. However, it is 
clear that there is still room for improvement for PreDiZ. 
4.1.3 Using a wide range of interaction data 
To the best of our knowledge, PreDiZ uses the widest range of experimentally 
verified PDZ interactions among the published PDZ interaction prediction algorithms. The 
PreDiZ’s interaction data was extracted from three proteome-wide large scale studies on C. 
elegans, M. musculus and H. sapiens, as well as the manually curated interaction 
database Domino. Using a wide range of data enables PreDiZ to make predictions for 
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more PDZ domains. However, including C. elegans interactions into our dataset lowered 
the results in cross-validation in our case. The reason is that including PDZ interactions 
from C. elegans introduced a large number of false negative results in the cross-
validations due to the poor performance on predicting C. elegans PDZ interactions. To 
validate this assumption, we excluded all C. elegans data from our database and used 
only mouse and human PDZ proteins to perform 10-fold cross-validation. The AUCs 
showed significant improvement from 0.82 to 0.89 and from 0.88 to 0.94 for PreDiZ-PSSM 
and PreDiZ-NB, respectively (Figure 7, Table 14). The AUC value of PreDiZ-NB is one of 
the best score among all published methods. We also performed tests on the unpublished 
mouse test sets, and the performance showed only a slight improvement on PreDiZ-NB, 
but not much change for PreDiZ-PSSM ( 
Table 15, Table S3, Table S4). This result suggested that PreDiZ didn’t use many C. 
elegans interactions to make prediction for PDZ domains in the mouse test set, as the 
PDZ domains from these two species do not share many similar SDRs. Overall, the results 
suggested the improvement on cross-validation tests were mainly contributed from 
excluding the C. elegans data, but the performance on making prediction on mouse PDZ 




Figure 7 ROC curves of 10-fold cross-validations for PreDiZ-PSSM and PreDiZ-NB using mouse 
and human interaction data 




TPR (%) SPC (%) MCC 
AUC 
PreDiZ-
PSSM 90.16 51.21 94.87 0.4742 
0.89 
PreDiZ-NB 93.98 67.38 97.06 0.6664 0.94 
 
Table 15 Performance of PreDiZ using only mouse and human interaction data on the unpublished 
mouse test set  
Predictor TPR FPR TP/FP AUC 
PreDiZ-PSSM  0.44 0.11 0.74 0.78 
PreDiZ-NB 0.40 0.18 0.38 0.70 
4.2 Comparisons between the PreDiZ and other methods 
We compared the PreDiZ with three state-of-the-art PDZ interaction prediction tools. 
The results presented in 3.1.2.2.1 suggested that the PreDiZ performed better than MDSM 
but not as good as the other recently published methods in the mouse test sets. In the test 
of using C. elegans PDZ domains, both PreDiZ and PepPePInt scored rather low true 
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positive rates, with the PreDiZ performing slightly better. Unfortunately, there is no 
negative interaction data on these C. elegans PDZ domains for us to do a comprehensive 
comparison. From the available information, it is suggested that PreDiZ is one of the best 
methods for predicting interactions for novel PDZ domains. 
4.3 Applications of PDZ domain-peptide interaction prediction 
4.3.1 Proteome-wide analyses  
PDZ domains are known to have evolved relatively late in eukaryotic cells. The 
results of proteome-wide analyses of five different species supported this theory. A larger 
number of PDZ domains and PDZ binding proteins were found in species higher up in the 
evolutional tree such as H. sapiens, M. musculus and D. rerio. The GO and KEGG 
analyses revealed a number of common features of human PDZ domains. Not surprisingly, 
the PDZ domain involvement in most of the enriched GO terms and KEGG pathways is 
well documented. 
4.3.2 PDZ binding motifs in the influenza A virus  
The mortality rate for H5N1 and H7N9 virus infections in human is much higher 
compared to that of seasonal influenza infections (93, 94). There are reports showed the 
PBM in NS1 proteins contribute to virulence of HPAI H5N1 virus (95-98). Previous studies 
also revealed that compared to HPAI H5N1 virus, the HPAI H7N9 virus did not have PBM 
in the NS1 proteins, instead having a PBM in the NA proteins. Hence, it was suspected 
that the loss of function from missing the PBM in H5N1’s NS1 proteins were regained by 
H7N9 virus through the PBM in their NA proteins (90). Our studies supported that the PBM 
on H5N1’s NS1 proteins and H7N9’s NA proteins regulate similar human biological 
process by PDZ-domain interactions. This finding may form the basis for further studies of 
the PBM in influenza A virus.  
5 Conclusions and future directions 
In this work, the PDZ domain-peptide interaction prediction tool PreDiZ has been 
developed. It is based on the SDR approach, which has been successfully applied in 
predicting protein-peptide interaction involving protein kinases and MHC class II proteins. 
A number of modifications has been made to apply the SDR approach to the PDZ domains, 
45 
 
including using a more sophisticated strategy to determine SDRs, and using both positive 
and negative interactions in the prediction. One of the advantages of PreDiZ is that it is 
able to work on a wide range of PDZ domains, including novel PDZ domains. However, 
there is room to improve the tool, especially to reduce the false positive rate. We also 
conducted proteome-wide analyses in human PDZ binding proteins. Lastly, we studied 
how H7N9’s NA and H5N1’s NS1 protein regulate human biological processes, and found 
the PBM in the NS1 proteins of H5N1 was replaced by the PBM in the NA proteins of 
H7N9.  
Improvements need to be made to PreDiZ to especially to reduce false positive 
predictions, in order for it to match the performance of the best available PDZ interaction 
prediction tool. At the time I started this project, there were only 22 PDZ complex 
structures that satisfied our selection criteria. However, the number of published PDZ 
structures have been increasing rapidly. Using more high quality structures will definitely 
have a positive impact on PreDiZ’s performance. In the future update of PreDiZ, using 
more available structures to derive SDRs will be a very important part of the work. We also 
believe that the SDR selection could be further optimised to improve accuracy of our 
predictions. Due to time constraints, we couldn’t employ a more sophisticate strategies of 
SDR identification, which could improve prediction accuracy. For example, a mutagenesis 
study conducted by Tonikian, et al. (46) showed that PDZ domain’s specificity for residues 
at position 0 and -2 of the PBM were affected by direct side chain interaction.  Specificity 
for position -1 was affected by both direct and indirect side chain interactions. Specificity 
for position -3 and -4 were affected by indirect ways. Different cut-offs of the four-
parameter-test could be adjusted according these information independently for each 
peptide position. The prediction result from unpublished mouse data set showed PreDiZ 
didn’t perform well on some PDZ domains. A potential solution to this problem would be 
using specific prediction models for each of the known PDZ domains and a general model 
for others. There are over 300 known PDZ domains, building prediction models for all of 
them is labour intensive. However, the four-parameter-test developed in this study can 
speed up the process by selecting SDRs automatically.  For the proteome-wide analyses, 
including extra contextual information, such as secondary structure of binding peptides 
and co-cellular localisation of PDZ domain and their binding partners, may improve the 
quality of predictions. Finally, we expect that the SDR method, along with the four-
parameter-test, can be used for other protein-peptide interaction domains.  
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6 Supplementary materials 
Table S1 Prediction statistics of individual PDZ domains from mouse test set using PreDiZ-NB 
(high threshold) 
PDZ Domain Name TP FN FP TN TPR FPR TP/FP Accuracy 
a1-syntrophin_1-1 10 6 8 24 0.63 0.25 1.25 0.71 
b1-syntrophin_1-1 9 7 9 23 0.56 0.28 1.00 0.67 
Cipp_03-10 0 8 0 40 0.00 0.00 - 0.83 
Cipp_05-10 0 2 12 34 0.00 0.26 0.00 0.71 
Cipp_08-10 0 1 8 39 0.00 0.17 0.00 0.81 
Cipp_09-10 3 2 7 36 0.60 0.16 0.43 0.81 
Cipp_10-10 1 4 13 30 0.20 0.30 0.08 0.65 
Dvl1_1-1 0 2 6 40 0.00 0.13 0.00 0.83 
Dvl2_1-1 1 2 5 40 0.33 0.11 0.20 0.85 
Dvl3_1-1 1 5 5 37 0.17 0.12 0.20 0.79 
Erbin_1-1 0 1 8 39 0.00 0.17 0.00 0.81 
g2-syntrophin_1-1 3 10 4 31 0.23 0.11 0.75 0.71 
Gm1582_2-3 2 7 11 28 0.22 0.28 0.18 0.63 
LIN-7A_1-1 6 4 11 27 0.60 0.29 0.55 0.69 
Lin7c_1-1 6 3 11 28 0.67 0.28 0.55 0.71 
Lrrc7_1-1 0 1 10 37 0.00 0.21 0.00 0.77 
Magi-1_2-6 7 17 6 18 0.29 0.25 1.17 0.52 
Magi-1_4-6 0 2 0 46 0.00 0.00 - 0.96 
Magi-1_6-6 9 5 10 24 0.64 0.29 0.90 0.69 
Magi-2_5-6 0 4 0 44 0.00 0.00 - 0.92 
Magi-2_6-6 6 3 13 26 0.67 0.33 0.46 0.67 
Magi-3_5-5 9 6 10 23 0.60 0.30 0.90 0.67 
MUPP1_01-13 2 0 10 36 1.00 0.22 0.20 0.79 
MUPP1_05-13 0 1 12 35 0.00 0.26 0.00 0.73 
MUPP1_10-13 0 2 7 39 0.00 0.15 0.00 0.81 
MUPP1_11-13 0 0 8 40 - 0.17 0.00 0.83 
MUPP1_12-13 0 0 2 46 - 0.04 0.00 0.96 
MUPP1_13-13 2 7 6 33 0.22 0.15 0.33 0.73 
NHERF-1_1-2 1 2 4 41 0.33 0.09 0.25 0.88 
NHERF-2_2-2 7 10 2 29 0.41 0.06 3.50 0.75 
Pdlim5_1-1 0 0 14 34 - 0.29 0.00 0.71 
Pdzk1_1-4 7 3 4 34 0.70 0.11 1.75 0.85 
Pdzk3_1-1 0 1 4 43 0.00 0.09 0.00 0.90 
PDZ-RGS3_1-1 0 13 0 35 0.00 0.00 - 0.73 
PSD95_1-3 3 5 6 34 0.38 0.15 0.50 0.77 
PTP-BL_2-5 2 2 7 37 0.50 0.16 0.29 0.81 
SAP102_3-3 2 3 16 27 0.40 0.37 0.13 0.60 
SAP97_1-3 3 5 6 34 0.38 0.15 0.50 0.77 
SAP97_3-3 3 4 15 26 0.43 0.37 0.20 0.60 
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Scrb1_1-4 5 0 18 25 1.00 0.42 0.28 0.63 
Scrb1_2-4 2 0 17 29 1.00 0.37 0.12 0.65 
Scrb1_3-4 13 7 7 21 0.65 0.25 1.86 0.71 
Shank3_1-1 10 4 4 30 0.71 0.12 2.50 0.83 
SLIM_1-1 0 0 7 41 - 0.15 0.00 0.85 
ZO-1_1-3 2 6 13 27 0.25 0.33 0.15 0.60 
ZO-2_1-3 1 4 14 29 0.20 0.33 0.07 0.63 
ZO-3_1-3 1 1 14 32 0.50 0.30 0.07 0.69 
TP is true positive. FN is false negative. FP is false positive. TN is true negative. TPR is true 
positive rate. FPR is false positive rate. 
Table S2 Prediction statistics of individual PDZ domains from mouse test set using PreDiZ-PSSM 
(high threshold) 
PDZ Domain Name TP FN FP TN TPR FPR TP/FP Accuracy 
a1-syntrophin_1-1 9 7 0 32 0.56 0.00 - 0.85 
b1-syntrophin_1-1 9 7 0 32 0.56 0.00 - 0.85 
Cipp_03-10 0 8 0 40 0.00 0.00 - 0.83 
Cipp_05-10 1 1 5 41 0.50 0.11 0.20 0.88 
Cipp_08-10 0 1 5 42 0.00 0.11 0.00 0.88 
Cipp_09-10 4 1 3 40 0.80 0.07 1.33 0.92 
Cipp_10-10 0 5 5 38 0.00 0.12 0.00 0.79 
Dvl1_1-1 0 2 0 46 0.00 0.00 - 0.96 
Dvl2_1-1 0 3 0 45 0.00 0.00 - 0.94 
Dvl3_1-1 0 6 0 42 0.00 0.00 - 0.88 
Erbin_1-1 0 1 0 47 0.00 0.00 - 0.98 
g2-syntrophin_1-1 5 8 0 35 0.38 0.00 - 0.83 
Gm1582_2-3 1 8 5 34 0.11 0.13 0.20 0.73 
LIN-7A_1-1 5 5 1 37 0.50 0.03 5.00 0.88 
Lin7c_1-1 5 4 1 38 0.56 0.03 5.00 0.90 
Lrrc7_1-1 0 1 0 47 0.00 0.00 - 0.98 
Magi-1_2-6 5 19 1 23 0.21 0.04 5.00 0.58 
Magi-1_4-6 0 2 0 46 0.00 0.00 - 0.96 
Magi-1_6-6 6 8 2 32 0.43 0.06 3.00 0.79 
Magi-2_5-6 0 4 0 44 0.00 0.00 - 0.92 
Magi-2_6-6 5 4 3 36 0.56 0.08 1.67 0.85 
Magi-3_5-5 7 8 1 32 0.47 0.03 7.00 0.81 
MUPP1_01-13 0 2 1 45 0.00 0.02 0.00 0.94 
MUPP1_05-13 0 1 6 41 0.00 0.13 0.00 0.85 
MUPP1_10-13 1 1 4 42 0.50 0.09 0.25 0.90 
MUPP1_11-13 0 0 6 42 - 0.13 0.00 0.88 
MUPP1_12-13 0 0 0 48 - 0.00 - 1.00 
MUPP1_13-13 5 4 0 39 0.56 0.00 - 0.92 
NHERF-1_1-2 1 2 12 33 0.33 0.27 0.08 0.71 
NHERF-2_2-2 3 14 1 30 0.18 0.03 3.00 0.69 
Pdlim5_1-1 0 0 0 48 - 0.00 - 1.00 
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Pdzk1_1-4 5 5 2 36 0.50 0.05 2.50 0.85 
Pdzk3_1-1 0 1 1 46 0.00 0.02 0.00 0.96 
PDZ-RGS3_1-1 0 13 0 35 0.00 0.00 - 0.73 
PSD95_1-3 5 3 0 40 0.63 0.00 - 0.94 
PTP-BL_2-5 2 2 5 39 0.50 0.11 0.40 0.85 
SAP102_3-3 4 1 3 40 0.80 0.07 1.33 0.92 
SAP97_1-3 5 3 0 40 0.63 0.00 - 0.94 
SAP97_3-3 4 3 3 38 0.57 0.07 1.33 0.88 
Scrb1_1-4 3 2 6 37 0.60 0.14 0.50 0.83 
Scrb1_2-4 1 1 4 42 0.50 0.09 0.25 0.90 
Scrb1_3-4 8 12 1 27 0.40 0.04 8.00 0.73 
Shank3_1-1 5 9 0 34 0.36 0.00 - 0.81 
SLIM_1-1 0 0 1 47 - 0.02 0.00 0.98 
ZO-1_1-3 0 8 5 35 0.00 0.13 0.00 0.73 
ZO-2_1-3 0 5 5 38 0.00 0.12 0.00 0.79 
ZO-3_1-3 0 2 5 41 0.00 0.11 0.00 0.85 
TP is true positive. FN is false negative. FP is false positive. TN is true negative. TPR is true 
positive rate. FPR is false positive rate. 
 
Table S3 Prediction statistics of individual PDZ domains from mouse test set using PreDiZ-NB with 
only mouse and human interaction data 
Domain Name TP FN FP TN TPR FPR TP/FP Accuracy 
a1-syntrophin_1-1 11 5 6 26 0.69 0.19 1.83 0.77 
b1-syntrophin_1-1 10 6 7 25 0.63 0.22 1.43 0.73 
Cipp_03-10 0 8 0 40 0.00 0.00 - 0.83 
Cipp_05-10 0 2 14 32 0.00 0.30 0.00 0.67 
Cipp_08-10 0 1 9 38 0.00 0.19 0.00 0.79 
Cipp_09-10 3 2 6 37 0.60 0.14 0.50 0.83 
Cipp_10-10 1 4 4 39 0.20 0.09 0.25 0.83 
Dvl1_1-1 0 2 4 42 0.00 0.09 0.00 0.88 
Dvl2_1-1 1 2 3 42 0.33 0.07 0.33 0.90 
Dvl3_1-1 1 5 3 39 0.17 0.07 0.33 0.83 
Erbin_1-1 0 1 7 40 0.00 0.15 0.00 0.83 
g2-syntrophin_1-1 3 10 2 33 0.23 0.06 1.50 0.75 
Gm1582_2-3 2 7 11 28 0.22 0.28 0.18 0.63 
LIN-7A_1-1 5 5 10 28 0.50 0.26 0.50 0.69 
Lin7c_1-1 5 4 10 29 0.56 0.26 0.50 0.71 
Lrrc7_1-1 0 1 8 39 0.00 0.17 0.00 0.81 
Magi-1_2-6 5 19 1 23 0.21 0.04 5.00 0.58 
Magi-1_4-6 0 2 0 46 0.00 0.00 - 0.96 
Magi-1_6-6 8 6 9 25 0.57 0.26 0.89 0.69 
Magi-2_5-6 0 4 0 44 0.00 0.00 - 0.92 
Magi-2_6-6 6 3 11 28 0.67 0.28 0.55 0.71 
Magi-3_5-5 9 6 8 25 0.60 0.24 1.13 0.71 
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MUPP1_01-13 2 0 4 42 1.00 0.09 0.50 0.92 
MUPP1_05-13 0 1 14 33 0.00 0.30 0.00 0.69 
MUPP1_10-13 0 2 8 38 0.00 0.17 0.00 0.79 
MUPP1_11-13 0 0 6 42 - 0.13 0.00 0.88 
MUPP1_12-13 0 0 2 46 - 0.04 0.00 0.96 
MUPP1_13-13 3 6 6 33 0.33 0.15 0.50 0.75 
NHERF-1_1-2 0 3 4 41 0.00 0.09 0.00 0.85 
NHERF-2_2-2 2 15 2 29 0.12 0.06 1.00 0.65 
Pdlim5_1-1 0 0 17 31 - 0.35 0.00 0.65 
Pdzk1_1-4 7 3 4 34 0.70 0.11 1.75 0.85 
Pdzk3_1-1 0 1 5 42 0.00 0.11 0.00 0.88 
PDZ-RGS3_1-1 0 13 0 35 0.00 0.00 - 0.73 
PSD95_1-3 2 6 7 33 0.25 0.18 0.29 0.73 
PTP-BL_2-5 2 2 9 35 0.50 0.20 0.22 0.77 
SAP102_3-3 2 3 17 26 0.40 0.40 0.12 0.58 
SAP97_1-3 2 6 7 33 0.25 0.18 0.29 0.73 
SAP97_3-3 3 4 16 25 0.43 0.39 0.19 0.58 
Scrb1_1-4 5 0 14 29 1.00 0.33 0.36 0.71 
Scrb1_2-4 1 1 14 32 0.50 0.30 0.07 0.69 
Scrb1_3-4 13 7 6 22 0.65 0.21 2.17 0.73 
Shank3_1-1 8 6 2 32 0.57 0.06 4.00 0.83 
SLIM_1-1 0 0 7 41 - 0.15 0.00 0.85 
ZO-1_1-3 4 4 10 30 0.50 0.25 0.40 0.71 
ZO-2_1-3 2 3 12 31 0.40 0.28 0.17 0.69 
ZO-3_1-3 0 2 14 32 0.00 0.30 0.00 0.67 
TP is true positive. FN is false negative. FP is false positive. TN is true negative. TPR is true 
positive rate. FPR is false positive rate. 
 
Table S4 Prediction statistics of individual PDZ domains from mouse test set using PreDiZ-PSSM 
with only mouse and human interaction data 
Domain Name TP FN FP TN TPR FPR TP/FP Accuracy 
a1-syntrophin_1-1 6 10 0 32 0.38 0.00 - 0.79 
b1-syntrophin_1-1 6 10 0 32 0.38 0.00 - 0.79 
Cipp_03-10 0 8 0 40 0.00 0.00 - 0.83 
Cipp_05-10 1 1 5 41 0.50 0.11 0.20 0.88 
Cipp_08-10 0 1 4 43 0.00 0.09 0.00 0.90 
Cipp_09-10 4 1 3 40 0.80 0.07 1.33 0.92 
Cipp_10-10 0 5 0 43 0.00 0.00 - 0.90 
Dvl1_1-1 0 2 0 46 0.00 0.00 - 0.96 
Dvl2_1-1 0 3 0 45 0.00 0.00 - 0.94 
Dvl3_1-1 0 6 0 42 0.00 0.00 - 0.88 
Erbin_1-1 0 1 0 47 0.00 0.00 - 0.98 
g2-syntrophin_1-1 4 9 0 35 0.31 0.00 - 0.81 
Gm1582_2-3 1 8 4 35 0.11 0.10 0.25 0.75 
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LIN-7A_1-1 5 5 1 37 0.50 0.03 5.00 0.88 
Lin7c_1-1 5 4 1 38 0.56 0.03 5.00 0.90 
Lrrc7_1-1 0 1 0 47 0.00 0.00 - 0.98 
Magi-1_2-6 5 19 1 23 0.21 0.04 5.00 0.58 
Magi-1_4-6 0 2 0 46 0.00 0.00 - 0.96 
Magi-1_6-6 3 11 2 32 0.21 0.06 1.50 0.73 
Magi-2_5-6 0 4 0 44 0.00 0.00 - 0.92 
Magi-2_6-6 2 7 3 36 0.22 0.08 0.67 0.79 
Magi-3_5-5 4 11 1 32 0.27 0.03 4.00 0.75 
MUPP1_01-13 0 2 0 46 0.00 0.00 - 0.96 
MUPP1_05-13 0 1 6 41 0.00 0.13 0.00 0.85 
MUPP1_10-13 0 2 4 42 0.00 0.09 0.00 0.88 
MUPP1_11-13 0 0 6 42 - 0.13 0.00 0.88 
MUPP1_12-13 0 0 0 48 - 0.00 - 1.00 
MUPP1_13-13 4 5 0 39 0.44 0.00 - 0.90 
NHERF-1_1-2 1 2 1 44 0.33 0.02 1.00 0.94 
NHERF-2_2-2 0 17 1 30 0.00 0.03 0.00 0.63 
Pdlim5_1-1 0 0 0 48 - 0.00 - 1.00 
Pdzk1_1-4 4 6 2 36 0.40 0.05 2.00 0.83 
Pdzk3_1-1 0 1 1 46 0.00 0.02 0.00 0.96 
PDZ-RGS3_1-1 0 13 0 35 0.00 0.00 - 0.73 
PSD95_1-3 5 3 0 40 0.63 0.00 - 0.94 
PTP-BL_2-5 2 2 3 41 0.50 0.07 0.67 0.90 
SAP102_3-3 4 1 3 40 0.80 0.07 1.33 0.92 
SAP97_1-3 5 3 0 40 0.63 0.00 - 0.94 
SAP97_3-3 4 3 3 38 0.57 0.07 1.33 0.88 
Scrb1_1-4 3 2 6 37 0.60 0.14 0.50 0.83 
Scrb1_2-4 1 1 4 42 0.50 0.09 0.25 0.90 
Scrb1_3-4 8 12 1 27 0.40 0.04 8.00 0.73 
Shank3_1-1 1 13 0 34 0.07 0.00 - 0.73 
SLIM_1-1 0 0 1 47 - 0.02 0.00 0.98 
ZO-1_1-3 1 7 5 35 0.13 0.13 0.20 0.75 
ZO-2_1-3 0 5 6 37 0.00 0.14 0.00 0.77 
ZO-3_1-3 0 2 6 40 0.00 0.13 0.00 0.83 
TP is true positive. FN is false negative. FP is false positive. TN is true negative. TPR is true 
positive rate. FPR is false positive rate. 
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